Sinha S, Sravanthi TV, Yuvaraj S, Manju SL, Doble M. 2-Amino-4-aryl thiazole: a promising scaffold identified as a potent 5-LOX inhibitor.
RSC Adv 2016. [DOI:
10.1039/c5ra28187c]
[Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Human 5-lipoxygenase (5-LOX) is a target for asthma and allergy treatment. Zileuton is the only marketed drug targeting this enzyme (IC50 ∼ 1 μM). The current study identifies a promising lead molecule which could be improved to match the activity of zileuton.
Collapse